Trobalt/Potiga (Epilepsy)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
3 Disease Overview 10
3.1 Classification of Seizures 12
3.2 Etiology and Pathophysiology 13
3.2.1 Etiology 13
3.2.2 Pathophysiology 16
3.2.3 Prognosis 21
3.2.4 Quality of Life 22
4 Disease Management 23
4.1 Diagnosis 23
4.2 Treatment Guidelines 24
4.3 Clinical Practice 25
5 Competitive Assessment 31
5.1 Overview 31
5.2 Strategic Competitor Assessment 33
6 Trobalt/Potiga (retigabine/ezogabine) 36
6.1 Overview 36
6.2 Therapeutic Role 37
6.3 Efficacy 37
6.4 Safety 37
6.5 SWOT Analysis 38
6.6 Forecast 38
7 Appendix 40
7.1 Bibliography 40
7.2 Abbreviations 42
7.3 Methodology 44
7.4 Forecasting Methodology 44
7.4.1 Prevalent Epilepsy Patients 44
7.4.2 Percent Drug-Treated Patients 45
7.4.3 General Pricing Assumptions 45
7.4.4 Individual Drug Assumptions 46
7.4.5 Generic Erosion 46
7.5 Physicians and Specialists Included in this Study 47
7.6 Primary Research – Prescriber Survey 48
7.7 About the Authors 48
7.7.1 Authors 48
7.7.2 Global Head of Healthcare 49
7.8 About GlobalData 50
7.9 Contact Us 50
7.10 Disclaimer 50